Laboratoire HRA-Pharma;The United States of America as represented by the Secretary, Department of Health and Human Services
发明人:
申请号：
EP13187859.7
公开号：
EP2684565B1
申请日:
2009.01.28
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17±-acetoxy-11²-[4- N , N -dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
